サマリー

新興国医薬品市場トップ5の概要、競合分析、2018-2027年予測

概要

新興国5ヶ国の医薬品産業プロファイルは、市場シェア、市場規模（2018-22年値、2027年予測）など、トップラインの定性的・定量的サマリー情報を提供します。また、主要な財務指標や市場内の競争圧力の分析など、主要企業に関する記述も掲載しています。

主要ハイライト

- これらの国々は、2022年に世界の医薬品産業に2,882億ドル貢献し、2007年から2011年の年間平均成長率（CAGR）は9.1%であった。新興国上位5カ国は2027年に4,517億ドルに達し、2022〜27年のCAGRは9.4%と予想される。
- 医薬品業界では、新興国上位5カ国の中で中国がトップで、2022年の市場売上は2,132億ドルに達する。次いでメキシコが255億ドル、インドが242億ドルとなっている。
- 中国は2027年に3,552億ドル、次いでメキシコが378億ドル、インドが326億ドルとなり、新興国上位5カ国で医薬品業界をリードすると予想される。

スコープ

- 新興5カ国医薬品市場の規模、成長、主要プレイヤーを特定することで、初級レベルの調査にかかる時間を短縮
- ファイブフォース分析により、新興5大医薬品市場の競争力および魅力度を判断
- 主要企業のプロフィールから、新興5大医薬品市場の主要企業の事業および財務実績の詳細を明らかにします。
- 新興5大医薬品市場の今後の成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加えることができます
- ブラジル、中国、インド、メキシコ、南アフリカのデータを比較し、それぞれの国について個別の章を設けています。

購入の理由

- 2022年の新興5カ国医薬品市場規模は？
- 2027年の新興5大医薬品市場規模は？
- 新興5大医薬品市場の競争力に影響を与える要因は何か？
- 過去5年間の市場の推移は？
- 新興5大医薬品市場における上位競合企業は？

ページTOPに戻る

目次

Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Aspen Pharmacare Holdings Ltd
13.2. Adcock Ingram Holdings Ltd
13.3. Novartis AG
13.4. Ache Laboratorios Farmaceuticos SA
13.5. EMS Sigma Pharma
13.6. Yangtze River Pharmaceutical Group
13.7. Shanghai Pharmaceuticals Holding Co Ltd
13.8. Yunnan Baiyao Group Co Ltd
13.9. Guangzhou Pharmaceutical Holdings Ltd
13.10. Sun Pharmaceutical Industries Ltd
13.11. Lupin Ltd
13.12. Dr. Reddy's Laboratories Limited
13.13. Aurobindo Pharma Ltd
13.14. Sanofi SA
13.15. Genomma Lab Internacional SAB de CV
13.16. Pfizer Inc.
14 Appendix
14.1. Methodology
14.2. About MarketLine

ページTOPに戻る

図表リスト

List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27
Table 4: South Africa pharmaceuticals market value: $ billion, 2017-22
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2022
Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27
Table 7: South Africa size of population (million), 2018–22
Table 8: South Africa gdp (constant 2005 prices, $ billion), 2018–22
Table 9: South Africa gdp (current prices, $ billion), 2018–22
Table 10: South Africa inflation, 2018–22
Table 11: South Africa consumer price index (absolute), 2018–22
Table 12: South Africa exchange rate, 2018–22
Table 13: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Table 16: Brazil size of population (million), 2018–22
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2018–22
Table 18: Brazil gdp (current prices, $ billion), 2018–22
Table 19: Brazil inflation, 2018–22
Table 20: Brazil consumer price index (absolute), 2018–22
Table 21: Brazil exchange rate, 2018–22
Table 22: China pharmaceuticals market value: $ billion, 2017-22
Table 23: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 24: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 25: China size of population (million), 2018–22
Table 26: China gdp (constant 2005 prices, $ billion), 2018–22
Table 27: China gdp (current prices, $ billion), 2018–22
Table 28: China inflation, 2018–22
Table 29: China consumer price index (absolute), 2018–22
Table 30: China exchange rate, 2018–22
Table 31: India pharmaceuticals market value: $ billion, 2017-22
Table 32: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 33: India pharmaceuticals market value forecast: $ billion, 2022–27
Table 34: India size of population (million), 2018–22
Table 35: India gdp (constant 2005 prices, $ billion), 2018–22
Table 36: India gdp (current prices, $ billion), 2018–22
Table 37: India inflation, 2018–22
Table 38: India consumer price index (absolute), 2018–22
Table 39: India exchange rate, 2018–22
Table 40: Mexico pharmaceuticals market value: $ billion, 2017-22
Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2022
Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2022–27
Table 43: Mexico size of population (million), 2018–22
Table 44: Mexico gdp (constant 2005 prices, $ billion), 2018–22
Table 45: Mexico gdp (current prices, $ billion), 2018–22
Table 46: Mexico inflation, 2018–22
Table 47: Mexico consumer price index (absolute), 2018–22
Table 48: Mexico exchange rate, 2018–22
Table 49: Aspen Pharmacare Holdings Ltd: key facts
Table 50: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 51: Aspen Pharmacare Holdings Ltd: Key Employees
Table 52: Adcock Ingram Holdings Ltd: key facts
Table 53: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 54: Adcock Ingram Holdings Ltd: Key Employees
Table 55: Novartis AG: key facts
Table 56: Novartis AG: Annual Financial Ratios
Table 57: Novartis AG: Key Employees
Table 58: Novartis AG: Key Employees Continued
Table 59: Ache Laboratorios Farmaceuticos SA: key facts
Table 60: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 61: EMS Sigma Pharma: key facts
Table 62: EMS Sigma Pharma: Key Employees
Table 63: Yangtze River Pharmaceutical Group: key facts
Table 64: Yangtze River Pharmaceutical Group: Key Employees
Table 65: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 66: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 67: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 68: Yunnan Baiyao Group Co Ltd: key facts
Table 69: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 70: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 71: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 72: Sun Pharmaceutical Industries Ltd: key facts
Table 73: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 74: Sun Pharmaceutical Industries Ltd: Key Employees
Table 75: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 76: Lupin Ltd: key facts
Table 77: Lupin Ltd: Annual Financial Ratios
Table 78: Lupin Ltd: Key Employees
Table 79: Dr. Reddy's Laboratories Limited: key facts
Table 80: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 81: Dr. Reddy's Laboratories Limited: Key Employees
Table 82: Aurobindo Pharma Ltd: key facts
Table 83: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 84: Aurobindo Pharma Ltd: Key Employees
Table 85: Sanofi SA: key facts
Table 86: Sanofi SA: Annual Financial Ratios
Table 87: Sanofi SA: Key Employees
Table 88: Sanofi SA: Key Employees Continued
Table 89: Genomma Lab Internacional SAB de CV: key facts
Table 90: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 91: Genomma Lab Internacional SAB de CV: Key Employees
Table 92: Pfizer Inc.: key facts
Table 93: Pfizer Inc.: Annual Financial Ratios
Table 94: Pfizer Inc.: Key Employees
Table 95: Pfizer Inc.: Key Employees Continued
Table 96: Maypo Farmaceutics SA de CV: key facts